for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Boryung Pharmaceutical Co., Ltd

003850.KS

Latest Trade

21,450.00KRW

Change

450.00(+2.14%)

Volume

1,569,943

Today's Range

20,600.00

 - 

21,900.00

52 Week Range

7,638.07

 - 

30,100.00

As of on the Korea Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
21,000.00
Open
20,750.00
Volume
1,569,943
3M AVG Volume
40.89
Today's High
21,900.00
Today's Low
20,600.00
52 Week High
30,100.00
52 Week Low
7,638.07
Shares Out (MIL)
49.74
Market Cap (MIL)
1,117,974.00
Forward P/E
32.51
Dividend (Yield %)
0.47

Latest Developments

More

S.Korea's Boryung Pharm Says Co-CEO Kim Eun-Sun Resigns For Personal Reason, Appoints An Jae-Hyun As New Co-CEO

Boryung Pharm to buy back shares at 5.57 bln won

Pharma Mar and South Korea's Boryung Pharm sign licensing deal for Zepsyre

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Boryung Pharmaceutical Co., Ltd

Boryung Pharm Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.

Industry

Biotechnology & Drugs

Contact Info

Boryung Bldg.

136, Changgyeonggung-ro, Jongno-gu

03127

South Korea

+82.2.7088000

http://www.boryung.co.kr

Executive Leadership

Eun Seon Kim

Chairman of the Board

Seung Ho Kim

Chairman

Jae Hyeon Ahn

Co-Chief Executive Officer, Director

Sam Su Lee

Co-Chief Executive Officer, Director

Yong Gwan Jeon

Vice President

Key Stats

1.67 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, KRW)

2018

0.5K

2019

0.5K

2020

0.6K

2021(E)

0.6K
EPS (KRW)

2018

439.189

2019

696.519

2021(E)

659.840
Price To Earnings (TTM)
36.84
Price To Sales (TTM)
1.99
Price To Book (MRQ)
3.14
Price To Cash Flow (TTM)
20.85
Total Debt To Equity (MRQ)
56.76
LT Debt To Equity (MRQ)
50.64
Return on Investment (TTM)
6.15
Return on Equity (TTM)
4.66

Latest News

Latest News

BRIEF-Boryung Pharm Agrees To Terminate $70 Mln Worth Contract With Novartis' Unit In Southeast Asia

* AGREES TO TERMINATE 85 BILLION WON ($70.09 million) WORTH CONTRACT WITH NOVARTIS' UNIT IN SOUTHEAST ASIA Source text for Eikon: https://bit.ly/2NwTDEF Further company coverage: ($1 = 1,212.6600 won)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up